Header
Header
Article

FDA OKs Accurian Nerve Ablation Platform for Chronic Pain



The minimally invasive ablative procedure destroys small areas of nerve tissue to stop it from sending pain signals, thereby reducing pain, Medtronic says.
Medscape Medical News

Source link

Back to top button